{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T20:13:38Z","timestamp":1793391218200,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T00:00:00Z","timestamp":1752624000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016819","name":"Octapharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016819","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.thromres.2025.109404","type":"journal-article","created":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T07:33:31Z","timestamp":1752651211000},"page":"109404","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["tPA-ROTEM identifies hyperfibrinolytic profile in a significant proportion of patients with bleeding disorder of unknown cause (BDUC)"],"prefix":"10.1016","volume":"253","author":[{"given":"A.L.L.","family":"Monard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Hellenbrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Verhezen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.A.M.","family":"Beckers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.C.M.","family":"Henskens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3281-926X","authenticated-orcid":false,"given":"F.C.J.I.","family":"Heubel-Moenen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.thromres.2025.109404_bb0005","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1111\/hae.14174","article-title":"Bleeding of unknown cause and unclassified bleeding disorders; diagnosis, pathophysiology and management","volume":"26","author":"Thomas","year":"2020","journal-title":"Haemophilia"},{"issue":"7","key":"10.1016\/j.thromres.2025.109404_bb0010","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/j.jtha.2024.03.005","article-title":"Standardization of definition and management for bleeding disorder of unknown cause: communication from the SSC of the ISTH","volume":"22","author":"Baker","year":"2024","journal-title":"J. Thromb. Haemost."},{"issue":"3","key":"10.1016\/j.thromres.2025.109404_bb0015","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3324\/haematol.10816","article-title":"High prevalence of bleeders of unknown cause among patients with inherited mucocutaneous bleeding. A prospective study of 280 patients and 299 controls","volume":"92","author":"Quiroga","year":"2007","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.thromres.2025.109404_bb0020","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1111\/hae.13775","article-title":"The bleeding score: useful in predicting spontaneous bleeding events in adults with bleeding of unknown cause?","volume":"26","author":"Relke","year":"2020","journal-title":"Haemophilia"},{"issue":"19","key":"10.1016\/j.thromres.2025.109404_bb0025","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1182\/blood.2020010038","article-title":"How I treat bleeding disorder of unknown cause","volume":"138","author":"Baker","year":"2021","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.thromres.2025.109404_bb0030","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1111\/jth.14529","article-title":"Thrombin-generating potential, plasma clot formation, and clot lysis are impaired in patients with bleeding of unknown cause","volume":"17","author":"Hofer","year":"2019","journal-title":"J. Thromb. Haemost."},{"issue":"2","key":"10.1016\/j.thromres.2025.109404_bb0035","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/ijlh.13124","article-title":"Characterization of a large cohort of patients with unclassified bleeding disorder; clinical features, management of haemostatic challenges and use of global haemostatic assessment with proposed recommendations for diagnosis and treatment","volume":"42","author":"MacDonald","year":"2020","journal-title":"Int. J. Lab. Hematol."},{"issue":"3","key":"10.1016\/j.thromres.2025.109404_bb0040","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.1111\/hae.13991","article-title":"Evaluation of thromboelastometry, thrombin generation and plasma clot lysis time in patients with bleeding of unknown cause: a prospective cohort study","volume":"26","author":"Veen","year":"2020","journal-title":"Haemophilia"},{"issue":"6","key":"10.1016\/j.thromres.2025.109404_bb0045","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1111\/bjh.18003","article-title":"Multiparameter platelet function analysis of bleeding patients with a prolonged platelet function analyser closure time","volume":"196","author":"Heubel-Moenen","year":"2022","journal-title":"Br. J. Haematol."},{"issue":"3","key":"10.1016\/j.thromres.2025.109404_bb0050","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00277-016-2893-6","article-title":"Fibrinolysis in patients with a mild-to-moderate bleeding tendency of unknown cause","volume":"96","author":"Gebhart","year":"2017","journal-title":"Ann. Hematol."},{"issue":"2","key":"10.1016\/j.thromres.2025.109404_bb0055","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12681","article-title":"Fibrinolytic assays in bleeding of unknown cause: improvement in diagnostic yield","volume":"6","author":"Valke","year":"2022","journal-title":"Res. Pract. Thromb. Haemost."},{"issue":"5","key":"10.1016\/j.thromres.2025.109404_bb0060","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/MBC.0000000000000444","article-title":"Laboratory evaluation of patients with undiagnosed bleeding disorders","volume":"27","author":"Alves","year":"2016","journal-title":"Blood Coagul. Fibrinolysis"},{"issue":"1","key":"10.1016\/j.thromres.2025.109404_bb0065","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1538-7836.2005.01709.x","article-title":"Evaluation of low PAI-1 activity as a risk factor for hemorrhagic diathesis","volume":"4","author":"Agren","year":"2006","journal-title":"J. Thromb. Haemost."},{"issue":"9","key":"10.1016\/j.thromres.2025.109404_bb0070","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1111\/jth.12645","article-title":"No increased systemic fibrinolysis in women with heavy menstrual bleeding","volume":"12","author":"Wiewel-Verschueren","year":"2014","journal-title":"J. Thromb. Haemost."},{"issue":"4","key":"10.1016\/j.thromres.2025.109404_bb0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0125069","article-title":"Increased plasma clot permeability and susceptibility to lysis are associated with heavy menstrual bleeding of unknown cause: a case-control study","volume":"10","author":"Szczepaniak","year":"2015","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.thromres.2025.109404_bb0080","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.blre.2014.09.003","article-title":"Fibrinolysis and the control of blood coagulation","volume":"29","author":"Chapin","year":"2015","journal-title":"Blood Rev."},{"issue":"4","key":"10.1016\/j.thromres.2025.109404_bb0085","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1055\/s-0037-1615669","article-title":"The expression of exercise-induced tPA activity in blood is regulated by the basal level of PAI-1","volume":"85","author":"Urano","year":"2001","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2025.109404_bb0090","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.thromres.2021.05.017","article-title":"Euglobulin clot lysis time reveals a high frequency of fibrinolytic activation in trauma","volume":"204","author":"Ilich","year":"2021","journal-title":"Thromb. Res."},{"issue":"5","key":"10.1016\/j.thromres.2025.109404_bb0095","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1160\/TH16-07-0572","article-title":"Mutation in a highly conserved glycine residue in strand 5B of plasminogen activator inhibitor 1 causes polymerisation","volume":"117","author":"Iwaki","year":"2017","journal-title":"Thromb. Haemost."},{"issue":"6","key":"10.1016\/j.thromres.2025.109404_bb0100","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1111\/j.1538-7836.2011.04288.x","article-title":"Life-threatening hemorrhage and prolonged wound healing are remarkable phenotypes manifested by complete plasminogen activator inhibitor-1 deficiency in humans","volume":"9","author":"Iwaki","year":"2011","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2025.109404_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12959-016-0076-2","article-title":"Validation of a modified thromboelastometry approach to detect changes in fibrinolytic activity","volume":"14","author":"Kuiper","year":"2016","journal-title":"Thromb. J."},{"issue":"7","key":"10.1016\/j.thromres.2025.109404_bb0110","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1111\/jth.14465","article-title":"Fibrinolysis in patients with chemotherapy-induced thrombocytopenia and the effect of platelet transfusion","volume":"17","author":"Heubel-Moenen","year":"2019","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2025.109404_bb0115","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.654174","article-title":"Serial EXTEM, FIBTEM, and tPA rotational thromboelastometry observations in the Maastricht intensive care COVID cohort-persistence of hypercoagulability and hypofibrinolysis despite anticoagulation","volume":"8","author":"Hulshof","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"issue":"1","key":"10.1016\/j.thromres.2025.109404_bb0120","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1080\/09537104.2017.1371290","article-title":"Screening for platelet function disorders with multiplate and platelet function analyzer","volume":"30","author":"Moenen","year":"2019","journal-title":"Platelets"},{"issue":"1\u20132","key":"10.1016\/j.thromres.2025.109404_bb0125","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.cca.2008.11.006","article-title":"Procarboxypeptidase U (TAFI) and the Thr325Ile proCPU polymorphism in patients with hereditary mucocutaneous hemorrhages","volume":"401","author":"Matus","year":"2009","journal-title":"Clin. Chim. Acta"},{"issue":"7","key":"10.1016\/j.thromres.2025.109404_bb0130","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1055\/s-0038-1639501","article-title":"Anxiety-related bleeding and thrombosis","volume":"44","author":"Hoirisch-Clapauch","year":"2018","journal-title":"Semin. Thromb. Hemost."},{"issue":"9","key":"10.1016\/j.thromres.2025.109404_bb0135","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.amjcard.2005.11.062","article-title":"Relation of depressive mood to plasminogen activator inhibitor, tissue plasminogen activator, and fibrinogen levels in patients with versus without coronary heart disease","volume":"97","author":"Lahlou-Laforet","year":"2006","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.thromres.2025.109404_bb0140","doi-asserted-by":"crossref","first-page":"30464","DOI":"10.1038\/srep30464","article-title":"Plasminogen activator Inhibitor-1 in depression: results from animal and clinical studies","volume":"6","author":"Jiang","year":"2016","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.thromres.2025.109404_bb0145","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.psc.2016.04.010","article-title":"Serotonin reuptake inhibitors and risk of abnormal bleeding","volume":"39","author":"Andrade","year":"2016","journal-title":"Psychiatr. Clin. North Am."},{"issue":"6","key":"10.1016\/j.thromres.2025.109404_bb0150","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.thromres.2010.09.017","article-title":"A selective serotonin reuptake inhibitor, citalopram, inhibits collagen-induced platelet aggregation and activation","volume":"126","author":"Tseng","year":"2010","journal-title":"Thromb. Res."},{"issue":"5","key":"10.1016\/j.thromres.2025.109404_bb0155","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/ijlh.12688","article-title":"Global assays of fibrinolysis","volume":"39","author":"Ilich","year":"2017","journal-title":"Int. J. Lab. Hematol."},{"issue":"8","key":"10.1016\/j.thromres.2025.109404_bb0160","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1111\/jth.13368","article-title":"A diagnostic approach to mild bleeding disorders","volume":"14","author":"Boender","year":"2016","journal-title":"J. Thromb. Haemost."},{"issue":"6","key":"10.1016\/j.thromres.2025.109404_bb0165","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1111\/j.1365-2516.2008.01834.x","article-title":"Plasminogen activator inhibitor type 1 deficiency","volume":"14","author":"Mehta","year":"2008","journal-title":"Haemophilia"},{"issue":"4","key":"10.1016\/j.thromres.2025.109404_bb0170","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/hae.13486","article-title":"The diagnostic accuracy of bleeding assessment tools for the identification of patients with mild bleeding disorders: a systematic review","volume":"24","author":"Moenen","year":"2018","journal-title":"Haemophilia"},{"issue":"1","key":"10.1016\/j.thromres.2025.109404_bb0175","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.transci.2018.02.020","article-title":"A new assay for global fibrinolysis capacity (GFC): investigating a critical system regulating hemostasis and thrombosis and other extravascular functions","volume":"57","author":"Amiral","year":"2018","journal-title":"Transfus. Apher. Sci."},{"issue":"11","key":"10.1016\/j.thromres.2025.109404_bb0180","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1111\/jth.15492","article-title":"Current practice and registration patterns among United Kingdom Haemophilia Centre Doctors\u2019 Organisation centers for patients with unclassified bleeding disorders","volume":"19","author":"Thomas","year":"2021","journal-title":"J. Thromb. Haemost."},{"issue":"2","key":"10.1016\/j.thromres.2025.109404_bb0185","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/hae.12811","article-title":"Unclassified bleeding disorders: outcome of haemostatic challenges following tranexamic acid and\/or desmopressin","volume":"22","author":"Obaji","year":"2016","journal-title":"Haemophilia"},{"issue":"11","key":"10.1016\/j.thromres.2025.109404_bb0190","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1055\/s-0041-1726344","article-title":"Outcome of surgical interventions and deliveries in patients with bleeding of unknown cause: an observational study","volume":"121","author":"Veen","year":"2021","journal-title":"Thromb. Haemost."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384825001549?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384825001549?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T15:27:39Z","timestamp":1761406059000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384825001549"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":38,"alternative-id":["S0049384825001549"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2025.109404","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"tPA-ROTEM identifies hyperfibrinolytic profile in a significant proportion of patients with bleeding disorder of unknown cause (BDUC)","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2025.109404","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"109404"}}